Tetrahydrocurcumin and octahydrocurcumin, the primary and final hydrogenated metabolites of curcumin, possess superior hepatic-protective effect against acetaminophen-induced liver injury: Role of CYP2E1 and Keap1-Nrf2 pathway

Title
Tetrahydrocurcumin and octahydrocurcumin, the primary and final hydrogenated metabolites of curcumin, possess superior hepatic-protective effect against acetaminophen-induced liver injury: Role of CYP2E1 and Keap1-Nrf2 pathway
Authors
Keywords
Octahydrocurcumin, Tetrahydrocurcumin, Acetaminophen, Oxidative stress, Keap1-Nrf2, CYP2E1
Journal
FOOD AND CHEMICAL TOXICOLOGY
Volume 123, Issue -, Pages 349-362
Publisher
Elsevier BV
Online
2018-11-10
DOI
10.1016/j.fct.2018.11.012

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started